MoneyWorks4Me

Lyka Labs - Quaterly Results

26 May 2026 Evaluate
The sales declined to Rs. 280.31 millions for the March 2026 quarter as compared to Rs. 305.17 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2026 is Rs. -297.71 millions as compared to Net Profit of Rs. 12.31 millions of corresponding quarter ended March 2025Operating profit Margin for the quarter ended March 2026 slipped to -39.72% as compared to 41.20% of corresponding quarter ended March 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 280.31 305.17 -8.15 1209.05 1346.97 -10.24 1209.05 1346.97 -10.24
Other Income 5.10 8.22 -37.96 39.74 27.60 43.99 39.74 27.60 43.99
PBIDT -39.72 41.20 -196.41 15.66 201.72 -92.24 15.66 201.72 -92.24
Interest 8.73 5.20 67.88 33.27 23.05 44.34 33.27 23.05 44.34
PBDT -278.59 36.00 -873.86 -247.75 178.67 -238.66 -247.75 178.67 -238.66
Depreciation 20.44 14.17 44.25 84.60 67.66 25.04 84.60 67.66 25.04
PBT -299.03 21.83 -1469.81 -332.35 111.01 -399.39 -332.35 111.01 -399.39
TAX -1.32 9.52 -113.87 -9.47 31.83 -129.75 -9.47 31.83 -129.75
Deferred Tax -4.70 2.76 -270.29 -17.75 4.57 -488.40 -17.75 4.57 -488.40
PAT -297.71 12.31 -2518.44 -322.88 79.18 -507.78 -322.88 79.18 -507.78
Equity 356.90 356.90 0.00 356.90 356.90 0.00 356.90 356.90 0.00
PBIDTM(%) -14.17 13.50 -204.96 1.30 14.98 -91.35 1.30 14.98 -91.35
Peers
Company Name CMP
Sun Pharma. Inds. 1851.00
Dr. Reddys Labs. 1199.60
Cipla 1398.30
Lupin 2093.70
Zydus Lifesciences 1181.00
View more..